The Europe synthetic biology market is projected to expand from US$ 3,111.58 million in 2021 to US$ 11,362.83 million by 2028, growing at a robust CAGR of 20.3% during this period.
A surge in start-up activity, supported by government funding aimed at boosting domestic synthetic biology capabilities, is playing a pivotal role in this growth. Companies like Siolta Therapeutics are at the forefront, developing therapeutic microbial consortia to prevent and treat inflammatory diseases. By analyzing clinical data and formulating mixed-species therapies for oral use, Siolta’s microbiome-based approach aims to intervene before immune dysfunction arises—offering an alternative to traditional allergy treatments. Its flagship candidate, STMC-103H, is currently under investigation for conditions such as allergic asthma, atopic dermatitis, and allergic rhinitis. Likewise, Kinnva Ltd., founded in 2017, is a rising player serving the biotech, cleantech, and agri-tech sectors. Leveraging advanced fermentation and processing technologies, Kinnva manufactures high-value biochemicals for use in the food, feed, nutraceutical, and cosmetics industries. Such innovative start-ups are significantly contributing to the market’s expansion across Europe.
📚Download Full PDF Sample Copy of Market Report @
https://www.businessmarketinsights.com/sample/BMIRE00025389
As vendors continue to introduce new features and technologies, they are well-positioned to attract a broader customer base and strengthen their presence in emerging markets—further fueling the growth of the European synthetic biology market during the forecast period.
Strategic insights into the Europe Synthetic Biology market deliver a data-driven analysis of the current industry landscape, highlighting emerging trends, leading players, and regional specificities. These insights provide actionable guidance, enabling businesses to stand out from competitors by uncovering untapped opportunities and crafting distinctive value propositions. By harnessing data analytics, stakeholders—including investors, manufacturers, and partners—can anticipate market developments and adapt proactively. With a forward-looking approach, these insights equip industry players to navigate change, seize growth opportunities, and secure long-term success in this evolving sector. Ultimately, well-informed strategies based on these insights empower decision-makers to enhance profitability and achieve their business goals in the European market.
Market leaders and key company profiles
Agilent Technologies, Inc.
Amyris
Codexis
Genscript Biotech corporation
Integrated DNA Technologies
Merck KGaA
New England Biolabs
Novozymes A/S
Thermo Fisher Scientific
Twist Bioscience
Europe Synthetic Biology Regional Insights
The geographic scope of the Europe Synthetic Biology refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
Europe Synthetic Biology Market Segmentation
The Europe synthetic biology market is analyzed based on products, technology, application, and country. Based on products, the market is segmented into enzymes, chassis organisms, oligonucleotides, and xeno-nucleic acids. The oligonucleotides segment dominated the market in 2020 and is expected to continue to grow at the fastest rate during the forecast period. Based on technology, the market is segmented into measurement & modeling, cloning & sequencing, genome engineering, gene synthesis, nanotechnology, and others. The gene synthesis segment dominated the market in 2020, while the genome engineering segment is expected to grow at the fastest CAGR during the forecast period. Based on application, the market is segmented into medical applications, industrial applications, food and agriculture, environmental applications, and others. The medical applications segment dominated the market in 2020 and is expected to grow at the highest CAGR during the forecast period. The Europe synthetic biology market is segmented into the UK, Germany, France, Italy, Spain, and Rest of Europe.
Agilent Technologies, Inc.; Amyris; Codexis; Genscript Biotech corporation; Integrated DNA Technologies; Merck KGaA; New England Biolabs; Novozymes A/S; Thermo Fisher Scientific; and Twist Bioscience are among the leading companies in the Europe synthetic biology market.
Can you see this our reports –
North America Ultrasonic Sensor Market – https://postyourarticle.com/north-america-ultrasonic-sensor-market-trends-size-segment-and-growth-by-forecast-to-2030-4/
North America Synchronous Condenser Market – https://github.com/businessmarketinsights985/business-market-insights/issues/20
North America Autonomous Navigation Market – https://findit.com/uwttwdjttmkjdpa/RightNow/northamerica-autonomous-navigations/9607fd98-0892-4c81-8fc7-1ce7835b530f
North America Biopharmaceuticals Market – https://businessmarketins02.blogspot.com/2025/05/north-america-biopharmaceuticals-market.html
Europe Microalgae-Based Products Market – https://sites.google.com/view/businessmarketinsights136/home
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Défense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications
Author’s Bio
Akshay
Senior Market Research Expert at Business Market Insights
